 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas
|
|
|
|
Phase III
|
|
|
|
GPOH-HIT-GBM-D
EU-205100, NCT00278278
|
|
| |
A Phase I/II Study of the Photon Radiosurgery System
|
|
|
|
Phase II, Phase I
|
|
|
|
CNS 0201
NCT00179907
|
|
| |
Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
R01 CA 89395-01
Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959
|
|
| |
A Multi-Center Phase I Study of AP23573 in Pediatric Patients With Advanced Solid Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
SUN08-01
NCT00704054
|
|
| |
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
CHNMC-07053
07053, CA180 121, NCT00788125
|
|
| |
Antineoplaston Therapy in Treating Children With Brain Tumors
|
|
|
|
Phase II
|
|
|
|
BC-BT-10
NCT00003458
|
|
| |
Interferon alfa After Radiation Therapy in Treating Young Patients With Glioma
|
|
|
|
Phase II
|
|
|
|
NCI-02-C-0193
NCT00041145
|
|
| |
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Treating Young Patients With Relapsed or Progressive Cancer
|
|
|
|
Phase II
|
|
|
|
DFCI-04343
04-343, NCT00357500
|
|
| |
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
|
|
|
|
Phase II
|
|
|
|
MSKCC-05122
NCT00445965
|
|
| |
Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma
|
|
|
|
Phase II
|
|
|
|
CCLG-CNS-2007-04
CNS 2007 04, EU-20746, EUDRACT-2007-001768-60, NCT00514397
|
|
